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Abstract
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are two
incurable neurodegenerative disorders that exist on a symptomological spectrum and share
both genetic underpinnings and pathophysiological hallmarks. Functional abnormality of TAR
DNA-binding protein 43 (TDP-43), an aggregation-prone RNA and DNA binding protein, is
observed in the vast majority of both familial and sporadic ALS cases and in ~40% of FTLD
cases, but the cascade of events leading to cell death are not understood. We have expressed
human TDP-43 (hTDP-43) in Drosophila neurons and glia, a model that recapitulates many of
the characteristics of TDP-43-linked human disease including protein aggregation pathology,
locomotor impairment, and premature death. We report that such expression of hTDP-43
impairs small interfering RNA (siRNA) silencing, which is the major post-transcriptional mecha-
nism of retrotransposable element (RTE) control in somatic tissue. This is accompanied by de-
repression of a panel of both LINE and LTR families of RTEs, with somewhat different ele-
ments being active in response to hTDP-43 expression in glia versus neurons. hTDP-43
expression in glia causes an early and severe loss of control of a specific RTE, the endoge-
nous retrovirus (ERV) gypsy. We demonstrate that gypsy causes the degenerative pheno-
types in these flies because we are able to rescue the toxicity of glial hTDP-43 either by
genetically blocking expression of this RTE or by pharmacologically inhibiting RTE reverse
transcriptase activity. Moreover, we provide evidence that activation of DNA damage-medi-
ated programmed cell death underlies both neuronal and glial hTDP-43 toxicity, consistent
with RTE-mediated effects in both cell types. Our findings suggest a novel mechanism in
which RTE activity contributes to neurodegeneration in TDP-43-mediated diseases such as
ALS and FTLD.
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Author summary
Functional abnormality of TAR DNA-binding protein 43 (TDP-43), an aggregation-
prone RNA and DNA binding protein, is observed in the vast majority of both familial
and sporadic ALS cases and in ~40% of FTLD cases, and mutations in TDP-43 are causal
in a subset of familial ALS cases. Although cytoplasmic inclusions of this mostly nuclear
protein are a hallmark of the disease, the cascade of events leading to cell death are not
understood. We demonstrate that expression of human TDP-43 (hTDP-43) in Drosophila
neurons or glial cells, which results in toxic cytoplasmic accumulation of TDP-43, causes
broad expression of retrotransposons. In the case of glial hTDP-43 expression, the endog-
enous retrovirus (ERV) gypsy causally contributes to degeneration because inhibiting
gypsy genetically or pharmacologically is sufficient to rescue the phenotypic effects. More-
over, we demonstrate that activation of DNA damage-mediated programmed cell death
underlies hTDP-43 and gypsymediated toxicity. Finally, we find that hTDP-43 pathology
impairs small interfering RNA silencing, which is an essential system that normally pro-
tects the genome from RTEs. These findings suggest a novel mechanism in which a storm
of retrotransposon activation drives neurodegeneration in TDP-43 mediated diseases
such as ALS and FTLD.
Introduction
RTEs are “genomic parasites”–“selfish” genetic elements that are coded within our genomes and
that replicate themselves via an RNA intermediate. After transcription, an RTE-encoded reverse
transcriptase generates a cDNA copy, and this cDNA is inserted into a new genomic location at
the site of double stranded DNA breaks created by an endonuclease activity encoded by the RTE
[1]. Unrestrained RTE activity has been demonstrated to be highly destructive to genomes, result-
ing in large-scale deletions and genomic rearrangements, insertional mutations, and accumula-
tion of DNA double strand breaks [2]. RTE-derived sequences constitute ~40% of the human
genome, a quantity which encompasses a surprisingly large number of functional RTE copies.
Although multiple interleaved, highly conserved gene silencing systems have evolved to protect
the genome by blocking RTE expression, certain RTEs are nevertheless expressed in some
somatic tissues [3, 4] and can replicate in a narrow window during neural development, leading
to de novo genomic insertions in adult brain [5–12]. Moreover, a gradual deterioration of RTE
suppression–and resultant increase in RTE activity–has been documented with advancing age in
a variety of organisms and tissues [13–20], including the brain [21]. One or more of the gene
silencing systems that normally block genotoxic RTE expression may therefore be weakened with
age. We advance the novel hypothesis that a broad and morbid loss of control of RTEs contrib-
utes to the cumulative degeneration observed with TDP-43 protein aggregation pathology that is
observed in a variety of neurodegenerative disorders, including ALS and FTLD, and that this loss
of control of RTEs is the result of a negative impact of TDP-43 pathology on general RTE sup-
pression mechanisms that are most prevalently relied upon in somatic tissue such as the brain.
TDP-43 is a member of the hnRNP family that homodimerizes to bind single stranded
RNA and DNA with UG/TG-rich motifs [22]. This pleiotropic protein was originally identi-
fied as a transcriptional repressor that binds to the TAR element of the HIV-1 retrovirus to
repress transcription [23]. TDP-43 is capable of shuttling back and forth from the nucleus to
the cytoplasm but is predominantly found in the nucleus in healthy cells. In cells that are
experiencing TDP-43 protein pathology, the protein accumulates in dense cytoplasmic inclu-
sions that include full-length protein, caspase cleavage products and C-terminal fragments of
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TDP-43, as well as abnormally phosphorylated and ubiquitinated protein [24–26]. TDP-43
protein pathology is currently thought to involve toxicity incurred by cytoplasmic aggregates,
interference with normal cytoplasmic function, depletion of normal nuclear TDP-43 stores, or
some combination thereof [27].
Functional abnormality of TDP-43, an aggregation-prone RNA binding protein, is com-
monly observed in a spectrum of neurodegenerative diseases that spans motor neuron deterio-
ration and progressive paralysis in ALS to dementia and cognitive decline in FTLD [28]. 90%
of ALS cases and a large fraction of FTLD cases are considered to be genetically sporadic, in
the sense that no known genetic lesion precipitates pathology. However, loss of nuclear TDP-
43 and accumulation of TDP-43 immunoreactive cytoplasmic inclusions is observed in nearly
all ALS and almost half of FTLD cases [28–30]. The mechanism that initiates the nucleation of
TDP-43 protein pathology in apparently genetically normal individuals is not understood
[29]. However, TDP-43 contains a low complexity domain in its C-terminal region, which is a
common feature of RNA binding proteins that exhibit aggregation pathology in a variety of
neurodegenerative disorders. Indeed a recent literature has established that cellular stress can
induce such low complexity domain proteins, including TDP-43, to undergo a concentration
dependent phase separation to form liquid droplets that over time can drive fibrilization [31–
33]. TDP-43 protein also is known to accumulate in cytoplasmic stress granules in response to
cellular stress [34]. Importantly, nuclear TDP-43 protein normally regulates splicing of TDP-
43 mRNA, leading to nonsense mediated decay of its own message [35]. Thus the formation of
cytoplasmic inclusions and clearance from the nuclear compartment that is observed in
patients is also associated with loss of this feedback inhibition onto TDP-43 mRNA, leading to
increased accumulation of cytoplasmic TDP-43 mRNA [36], which likely exacerbates forma-
tion of cytoplasmic inclusions.
Animal models of TDP-43 related disorders–and neurodegenerative disorders in general–
have taken advantage of the concentration dependence of low complexity domain protein
aggregation [37]. Most animal models of neurodegenerative diseases therefore have involved
transgenic expression to increase protein concentration above endogenous levels, and repro-
duce many of the signatures of human disease, which in the case of TDP-43 includes aggrega-
tion of TDP-43 protein in cytoplasmic inclusions and downstream neurological defects [28,
38, 39]. Although such animal models are imperfect representations of what is largely a spo-
radically occurring disorder, they have enabled the delineation of a myriad of cellular roles for
TDP-43 [28, 40] and have provided the means to uncover genetic interactions between TDP-
43 and other genes that are implicated in neurodegenerative disorders [41–44]. TDP-43
pathology in animal models is now understood to cause global alterations in mRNA stability
and splicing, de-repression of cryptic splicing, and biogenesis of some microRNAs (miRNAs)
[28, 29, 38, 39, 45–47]. In principle, any of the cellular impacts of TDP-43 protein pathology
could contribute to disease progression either alone or in combination. However, no clear con-
sensus has yet emerged regarding the underlying causes of neurodegeneration in TDP-43
pathologies.
The RTE hypothesis investigated here is motivated by a series of prior observations. First,
as mentioned above, LINE 1 RTEs are expressed in some somatic tissue [3, 4] and can actively
replicate during normal brain development, leading to de novo genomic insertions in adult
brain tissue [5–12], although the frequency of de novo insertions per cell is still hotly debated
[48, 49]. Second, increased RTE activity occurs in the brain during aging [21]. Moreover, ele-
vated expression of RTEs has been detected in a suite of neurodegenerative diseases [50–57]
and reverse transcriptase biochemical activity of unknown origin has been shown to be present
in both serum and cerebrospinal fluid (CSF) of HIV-negative ALS patients [58–61]. More
recently, a specific RTE, the human ERV HERV-K, was found to be expressed in post-mortem
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cortical tissue of ALS patients and their blood relatives [50, 55, 58] and transgenic expression
of the HERV-K Envelope (ENV) protein in mice is sufficient to cause motor neuron toxicity
[55]. Finally, we have previously predicted via meta-analysis of RNA Immunoprecipitation
(RIP) and Crosslinked RIP (CLIP) sequencing data that TDP-43 protein binds broadly to
RTE–derived RNA transcripts in rodent and human brain tissue and that this binding is selec-
tively lost in cortical tissue of FTLD patients [54]. However to date, no studies exist which
address whether TDP-43 pathology causes endogenous RTEs to become expressed in vivo, no
reports have probed the functional impact of TDP-43 pathology on the natural mechanisms of
RTE suppression employed by somatic tissue such as the brain, and no studies have investi-
gated the toxic effects of endogenous RTE activation on nervous system function.
The destructive capacity of RTEs has been extensively documented in many other biological
contexts, including a wealth of seminal data from Drosophila melanogaster [62–64]. To test
whether RTEs play a role in TDP-43 mediated neurodegeneration, we used an established Dro-
sophila transgenic model which afforded the means to examine whether RTE activation caus-
ally contributes to TDP-43 mediated toxicity and cell death. We found that several hallmarks
of TDP-43-induced degeneration are the result of activation of the gypsy ERV, an RTE that is
structurally related to HERV-K, and that this activation leads to DNA damage mediated cell
death. Moreover, we uncovered an inhibitory effect of TDP-43 expression on small interfering
RNA (siRNA) mediated silencing, leading to broad activation of a panel of RTEs. These find-
ings strongly suggest a broad impact of TDP-43 pathology on general RTE activity.
Results
Neuronal or glial expression of hTDP-43 induces RTE expression
In order to determine whether RTEs contribute to TDP-43 pathological toxicity, we implemented
an established animal model in which hTDP-43 is transgenically expressed in Drosophila. As
with other animal models, including mouse, rat, fish, and C elegans, such expression reproduces
many neuropathological hallmarks of human disease, likely via interference with endogenous
protein(s) function [27, 38, 39, 65, 66]. In Drosophila, there is an endogenous putative ortholog of
TDP-43, TBPH. Null mutations in TBPH in flies are lethal [67], as is the case with mammalian
TDP-43. Hypomorphic loss of TBPH results in neurodevelopmental defects as with the mamma-
lian gene. Overexpression-mediated toxicity has formed the basis of the preponderance of studies
on TDP-43 in animal models, and has revealed much of what is known regarding TDP-43 pro-
tein function and dysfunction, leading to the dominant hypotheses regarding mechanisms of
pathogenesis wherein toxic cytoplasmic aggregates are thought to contribute to disease progres-
sion [27–29, 39, 40, 66, 68]. To test the impact of expressing hTDP-43 on RTE expression, we
first used RNA sequencing (RNA-seq) to profile transcript abundance. In patient tissue, TDP-43
protein pathology is observed in both neurons and glial cells [29] and an emerging literature has
implicated glial cell toxicity in ALS [69–71]. Toxicity of TDP-43 in glia has similarly been docu-
mented in animal models, including in Drosophila [72–75]. We therefore examined the effects of
transgenic hTDP-43 expression in the neuronal versus glial compartments of the brain.
We conducted paired-end Illumina based RNA-seq on head tissue of flies expressing either
pan-neuronal (ELAV > hTDP-43) or pan-glial (Repo> hTDP-43) hTDP-43 compared with
control flies that carried the hTDP-43 transgene alone with no Gal4 driver (hTDP-43 / +). We
generated two independent sequencing libraries for each genotype from a population of ani-
mals that were 8–10 days post-eclosion. We generated a total of ~900 million reads, or about
150 million reads per sample (S1 Table), and conducted differential expression analysis (see
methods). In order to identify effects both on gene transcripts and RTE transcripts (Fig 1A–
1D; S2A and S3B Tables), we included reads that map to repetitive elements using an analysis
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pipeline that we have previously reported [54, 76]. Both glial (Repo> hTDP-43) and neuronal
(ELAV > hTDP-43) expression of hTDP-43 caused differential expression of a number of cel-
lular transcripts (Fig 1A and 1C; S2A and S3A Tables) and transposons, most of which were
RTEs or Class I elements (Fig 1B and 1D; S2B and S3B Tables). In the case of differentially
expressed genes, a broad spectrum of cellular processes were represented (see S2A and S3A
Tables), with both increases and decreases in expression level seen for many genes. This is
broadly consistent with previously reported transcriptome analysis using tissue from ALS
patients [77]. In fact, the differentially expressed transcripts identified in our RNAseq experi-
ments were significantly enriched for orthologs of genes that are implicated in ALS (ALS
KEGG gene list; S1 Fig and S2C Table). In contrast with differentially expressed genes, when
examining transposon transcripts the majority of those that were differentially expressed
exhibited elevated levels in response to hTDP-43 expression. This was particularly striking for
glial TDP-43 expression (Repo> hTDP-43; Fig 1D), where 23 of 29 differentially expressed
transposons showed higher levels relative to controls. The majority of the differential effects
were observed in RTEs (Class I elements), although a few Class II elements were also repre-
sented (Fig 1B and 1D).
It is also notable that while some RTE expression was elevated with both neuronal and glial
hTDP-43 expression, there were several cases where effects were uniquely detected with only
glial or only neuronal hTDP-43 expression. For example, the HeT-A LINE RTE and the mdg3,
HMS-Beagle, gtwin and 3S18 LTR RTEs were elevated with either glial or neuronal expression
of hTDP-43. However, the TART and TAHRE LINE RTEs and the Stalker2 and mdg1 LTR
RTEs were only elevated in response to neuronal hTDP-43 expression, while a broad host of
RTEs’ expression was elevated specifically in response to hTDP-43 expression in glia. Notable
among these is the gypsy element, which we have previously demonstrated to be progressively
de-repressed and even actively mobile with advanced age in brain tissue [21]. We cannot for-
mally rule out the possibility that some of the differences between differentially expressed
RTEs in Repo> hTDP-43 vs Elav> hTDP-43 may result from variation in copy number of
specific TEs between the two Gal4 strains. But we think this is unlikely to be a major contribut-
ing factor because all of the strains were backcrossed to the same wild type strain for a mini-
mum of 5 generations prior to the experiments. In the case of gypsy, expression levels are
significantly increased in response to pan-glial hTDP-43 expression (Repo> hTDP-43) rela-
tive to controls (hTDP-43 / +) but no significant effect was observed with pan-neuronal
expression of hTDP-43 (ELAV > hTDP-43) (Fig 1B, 1D, and 1E).
We selected the gypsyRTE as a candidate of interest to test the functional impact of loss of
endogenous RTE suppression in response to hTDP-43 expression for several reasons. First,
although gypsywas not the most abundantly expressed RTE in the RNA seq data, this element
is known to be one of the most active natural transposons in Drosophila melanogaster, and is
responsible for a high fraction of the spontaneous mutations that have been identified. Second,
we have previously documented that gypsy is capable of replicating and generating de novo
insertions in brain during advanced age [21]. Third, gypsy is an ERV with functional similarity
to HERV-K, which is expressed in some ALS patients [50, 55]. And finally, because of intense
prior investigation of the biology of this RTE, extant molecular genetic reagents provided
the means to both perturb and detect gypsy function. We began by performing quantitative
RT-PCR (qPCR) for both ORF2 (Pol) and ORF3 (ENV) of gypsy on head tissue of flies express-
ing either pan-neuronal (ELAV > hTDP-43) or pan-glial (Repo> hTDP-43) hTDP-43. Be-
cause disease risk is age dependent and symptoms in ALS patients are progressive, we also
examined the compounding effects of age. At two relatively young ages (2–4 and 8–10 days
post-eclosion) we observe a dramatic increase in expression of both ORFs (Fig 2A and 2B) of
gypsy specifically in flies expressing hTDP-43 in glia. In contrast, flies expressing neuronal
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Fig 1. Neuronal and glial hTDP-43 expression results in induction of RTE expression. Differential expression of many genes and RTEs are
detected in response to either neuronal or glial expression of hTDP-43 in head tissue of 8–10 day old flies (N = 2 biological replicates per genotype).
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hTDP-43 experience a wave of gypsy expression at the population level that occurs much later
in age (S2A Fig for ORF3; similar effects seen for ORF2) in a similar manner to genetic controls
that do not express hTDP-43 (see also: [21]). These flies do not show a significant impact of
hTDP-43 expression on gypsy transcript levels. This is entirely consistent with the RNA-seq
analyses (Fig 1B and 1D), where gypsy expression was found to be increased in head tissue spe-
cifically in response to glial hTDP-43 expression, but not to expression of hTDP-43 in neurons.
Importantly, different genomic copy number or basal levels of gypsy expression between the
parental Elav-Gal4 and Repo-Gal4 lines are unlikely to underlie the separate effects that we
observe on gypsywhen driving hTDP-43 expression in either neurons or glia (S2A.5 and S2A.6
Fig). Taken together, the RNA-seq and qPCR experiments confirm that gypsyRTE RNA levels
are significantly and precociously elevated in response to pan-glial hTDP-43 expression.
Whole mount immunolabeling of brains using a monoclonal antibody directed against the
gypsy ENV glycoprotein [21, 78] likewise shows early (5–8 days post-eclosion) and acute accu-
mulation of strongly immunoreactive puncta particularly in brains of flies expressing glial
hTDP-43 (Fig 2C; for quantification see S2B Fig). These intense puncta are observed through-
out the superficial regions, which contain the majority of cell somata, as well as in deeper neu-
ropil (Fig 2C) and persist into older ages. In contrast, we do not observe neuronal hTDP-43
expression to cause elevated gypsy levels above that seen in wild type flies at any time point
with either qPCR or immunolabeling (Fig 2C and S2A Fig). Given that effects of glial hTDP-
43 expression on gypsy ENV immunoreactivity were so robust in 5–8 day old animals, we
examined ENV at earlier time points. We found that in animals expressing hTDP-43 in glia,
there is little detectable gypsy ENV protein expression at 0 days (immediately following eclo-
sion). In brains from animals 3 days post eclosion, we observe regional puncta with a variable
intensity and spatial location (S2C Fig) although this effect was difficult to quantify because of
its variability.
Neuronal and glial hTDP-43 expression causes age-dependent
neurological deterioration
We next examined the relative impact of glial and neuronal hTDP-43 expression on the physi-
ological health of the animal. As previously documented [73–75], we see effects with either
neuronal or glial expression. However we observe differing severity and time courses, with
effects of glial expression being more acute than those observed with expression in neurons.
Flies expressing hTDP-43 in neurons exhibit significant locomotor impairment at 1–5 days
post-eclosion, and flies expressing glial hTDP-43 show more severe locomotor impairment at
this same age. This effect is further exacerbated by 5–10 days post-eclosion; at which point the
animals expressing hTDP-43 in glia are largely immobile (Fig 3A). As previously reported [68,
73, 74, 79–82], flies expressing neuronal hTDP-43 exhibit reduced lifespan in comparison to
genetic controls. But flies expressing hTDP-43 in glia display an even more severely reduced
lifespan (Fig 3B). We further observe rampant cell death as detected by terminal deoxynucleo-
tidyl transferase dUTP nick end labeling (TUNEL) in the brains of flies expressing hTDP-43 in
(A) Neuronal (Elav > hTDP-43) expression of hTDP-43 results in both increases and decreases in expression of a broad variety of cellular transcripts
(See S2A Table). (B) A panel of transposons, including many RTEs, also are impacted, with most exhibiting elevated expression (See S2B Table). (C)
Glial expression of hTDP-43 (Repo > hTDP-43) also results in numerous transcriptome alterations, with many transcripts either increasing or
decreasing in abundance (See S3A Table). (D) Many transposons, most of which are RTEs, exhibit elevated expression levels in response to glial
hTDP-43 expression (See S3B Table). Several RTEs display elevated expression in response to both glial and neuronal hTDP-43 expression,
however a number also exhibit specificity in response to either glial or neuronal hTDP-43 expression (compare Fig 1B and 1D). (E) The gypsy ERV
exhibits elevated expression only in response to glial, but not neuronal, hTDP-43 expression. See methods for details regarding analysis pipeline,
including statistical analysis.
doi:10.1371/journal.pgen.1006635.g001
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glia as early as 5 days post-eclosion (Fig 3C). Similarly, with transmission electron microscopy
(TEM; Fig 3D) we observe profuse proapoptotic nuclei in brains of 12 day-old flies expressing
glial hTDP-43. In contrast, driving expression of hTDP-43 in neurons under the OK107-Gal4
Fig 2. Glial hTDP-43 expression results in early and dramatic de-suppression of the gypsy ERV. (A) Transcript levels of gypsy ORF2 (Pol) as
detected by qPCR in whole head tissue of flies expressing hTDP-43 in neurons (ELAV > hTDP-43) versus glia (Repo > hTDP-43) at a young (2–4
Day) or aged (8–10 Day) time point. Transcript levels normalized to Actin and displayed as fold change relative to flies carrying the hTDP-43
transgene with no Gal4 driver (hTDP-43 / +) at 2–4 Days (means + SEM). A two-way ANOVA reveals a significant effect of genotype (p < 0.0001) but
no effect of age (p = 0.5414). N = 8 for all groups. (B) An equivalent analysis shows that gypsy ORF3 (Env) likewise displays a significant effect of
genotype (p < 0.0001) and no effect of age (p = 0.6530). N = 4 for the 2–4 Day cohort and N = 5 for the 8–10 Day cohort. (C) Central projections of
whole mount brains immunostained with a monoclonal antibody directed against gypsy ENV protein reveals dramatic, early accumulation of ENV
immunoreactive puncta in brains expressing glial hTDP-43 (5–8 Days) in comparison to both age-matched genetic controls (ELAV / +; Repo / +;
hTDP-43 / +) and flies expressing neuronal hTDP-43. This effect persists out to 19–25 Days post-eclosion. ELAV / +, 5–8 Day (N = 3), 19–25 Day
(N = 4); Repo / +, 5–8 Day (N = 3), 19–25 Day (N = 3); hTDP-43 / +, 5–8 Day (N = 5), 19–25 Day (N = 2); ELAV > hTDP-43, 5–8 Day (N = 2), 19–25
Day (N = 4); Repo > hTDP-43, 5–8 Day (N = 7), 19–25 Day (N = 8).
doi:10.1371/journal.pgen.1006635.g002
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driver, which provides high levels of expression in the well-defined and easily imaged popula-
tion of central nervous system (CNS) neurons that constitute the mushroom body, results in
little to no increase in TUNEL labeling (consistent with a previous report: [81]) even when the
flies were aged to 30 days (S3A Fig). The relative expression of hTDP-43 under the two major
Gal4 drivers we are using, Repo-Gal4 (glia) and ELAV-Gal4 (neurons), does not differ with
age, suggesting that divergent age effects on expression level cannot account for the observed
differences in toxicity and impact on physical health (S3D and S3E Fig; respectively). Further-
more, we do not observe any effect of hTDP-43 expression on levels of the endogenous fly
ortholog, TBPH, regardless of cell type of expression (S3F Fig; S4 Table). Thus, the phenotypes
that we observe are not caused by indirect effects on TBPH transcript abundance but instead
Fig 3. Neuronal and glial hTDP-43 expression induces physiological impairment and toxicity with varying severity. (A) Flies expressing glial
hTDP-43 display extreme locomotor impairment at 1–5 days post-eclosion in the Benzer fast phototaxis assay, while flies expressing neuronal hTDP-43
demonstrate a slight locomotor deficit in comparison to genetic controls (one-way ANOVA, p < 0.0001). This trend continues and is exacerbated by 5–10
days post-eclosion (one-way ANOVA, p < 0.0001). Four biological replicates performed for each experiment. (B) Lifespan analysis of flies expressing
neuronal versus glial hTDP-43 in comparison to genetic controls. (C) Central projections of whole-mount brains reveals a stark increase in TUNEL-
positive cells in flies expressing glial hTDP-43 in comparison to genetic controls at 5 days post-eclosion. N = 16 for Repo / + and N = 18 for Repo > hTDP-
43. (D) TEM likewise reveals rampant apoptosis in the neuropil of flies expressing glial hTDP-43 at 12 days post-eclosion. Arrowheads indicate pro-
apoptotic nuclei, as identified by morphology.
doi:10.1371/journal.pgen.1006635.g003
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derive from toxicity of the hTDP-43 transgene itself. The levels of expression of the hTDP-43
transgene relative to the endogenous TBPH gene also are similar to what has been reported in
rodent models (S4 Table). As is true in other animal models and in human patients, we cannot
readily distinguish whether the effects we observe are due to toxic gain of function, dominant
interference with an endogenous protein, or some combination thereof. Importantly, however,
we can detect a disease specific phosphorylated isoform of hTDP-43 (S3B Fig) as well as cyto-
plasmic accumulation and nuclear clearance of the protein (S3C Fig), implying that the
human protein is being processed in the CNS of the fly as it is thought to be in the disease state
in human tissue.
RTE and Chk2 activity mediate effects of hTDP-43 on lifespan and cell
death
Our observation that a panel of RTEs are expressed in response to hTDP-43 transgene expres-
sion, along with the extensively documented toxic effects of loss of control of RTEs in other
biological contexts [21, 62–64] and our observation that the gypsyRTE itself can actively repli-
cate and generate de novo insertional mutations in brain tissue during aging [21], and in
response to the hTDP-43 transgene, suggested the possibility that loss of gypsy silencing might
in fact account for a portion of the physiological toxicity observed with hTDP-43 expression in
glia. To test whether the Drosophila ERV gypsy causally contributes to the harmful effects of
hTDP-43, we used a previously published inverted repeat (IR) “RNAi” construct [57] directed
against gypsy ORF2 (gypsy(IR)) that is sufficient to reduce the expression of gypsy by approxi-
mately 50% in head tissue of 28-day old animals (S4A Fig). We found that co-expression of
this gypsy(IR) substantially ameliorates the lifespan deficit induced by glial hTDP-43 expres-
sion (Fig 4A). This effect is not observed when a control IR construct is co-expressed with
hTDP-43 in glial cells (Repo> hTDP-43 + GFP(IR); Fig 4B), and neither the gypsy(IR) nor the
GFP(IR) constructs, when expressed alone under Repo-Gal4 (S4B Fig) or ELAV-Gal4 (S4C
Fig) or when present without a Gal4 driver (S4D Fig), has such an effect on lifespan. Therefore
activation of gypsy is responsible for a substantial portion of the toxicity that we observe when
hTDP-43 is expressed in glia, which results in drastically premature death in these animals. In
contrast, co-expression of gypsy(IR) does not rescue the lifespan deficit exhibited by animals
expressing hTDP-43 in neurons (Fig 4C). This is in accordance with our observations from
RNA-seq (Fig 1B and 1D), qPCR (Fig 2A and 2B; S2A.1–S2A.3 Fig) and immunolabeling (Fig
2C) that neuronal expression of hTDP-43 also does not elevate gypsy expression above wild
type levels at any given time point over the course of lifespan. The glial specificity of gypsy(IR)
lifespan rescue is consistent with our observation that gypsy expression is induced specifically
when TDP-43 is expressed in glia, lending credence to the conclusion that gypsy is causally par-
ticipating in the resulting degenerative phenotype We of course cannot rule out the possibility
that the gypsy-RNAi construct may also impact gypsy family RTEs that share sequence homol-
ogy to gypsy. The conclusion that RTEs contribute to TDP-43 toxicity is further supported by
the mild but significant lifespan extension that we observe with pharmacological inhibition of
the reverse transcriptase activity that is essential for all RTE replication (S5E, S5F, S5G and
S5H Fig).
RTE replication involves reverse transcription, generation of chromosomal DNA breaks,
and integration of the RTE cDNA copy. DNA damage is therefore associated with either abor-
tive or successful attempts at RTE replication and such DNA damage is thought to be a major
source of cellular toxicity caused by RTE activity because it activates Chk2 signaling, which
leads to programmed cell death. To test whether the harmful effects of hTDP-43 are in fact
mediated by DNA damage, we capitalized on the previously documented ability of mutations
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Fig 4. gypsy ERV expression contributes to hTDP-43 mediated toxicity. (A) Lifespan analysis shows that
co-expression of gypsy(IR) (Repo > gypsy(IR) + hTDP-43) partially rescues the lifespan deficit exhibited by
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in Chk2 to mask the toxic effects of RTE-induced DNA damage [83, 84]. Importantly, muta-
tions in Chk2 do not prevent accumulation of DNA damage; rather they prevent the signaling
required for the cell to recognize that DNA damage has occurred and respond by committing
to a programmed cell death pathway [85]. We therefore employed an IR construct directed
against loki (loki(IR)), the Drosophila ortholog of chk2, which is sufficient to significantly reduce
levels of endogenous loki mRNA in head tissue of 28-day old animals (S5A Fig). Remarkably,
co-expression of loki(IR) with hTDP-43 is able to fully rescue the lifespan deficit caused by
hTDP-43 expression in glia (Fig 5A) or neurons (Fig 5B). These findings support the conclusion
that DNA damage makes a major contribution to the loss of lifespan induced by either neuronal
or glial expression of hTDP-43. This conclusion is supported by our RNA-seq findings, in
which we observe that in each case the expression of a panel of RTEs is activated. Although neu-
ronal hTDP-43 expression does not impact the levels of the gypsyRTE specifically, several other
RTEs exhibit elevated expression (see: Fig 1B). Importantly, this extension of lifespan is not
seen with co-expression of a control IR construct (Repo> hTDP-43 + GFP(IR); Fig 4B), and
neither the GFP(IR) nor loki(IR) constructs when expressed individually under Repo-Gal4 or
ELAV-Gal4 or present without a Gal4 driver (S4B–S4D Fig), have such an effect on lifespan on
their own. These data suggest that Loki/Chk2 activity makes a major contribution to the patho-
logical toxicity of hTDP-43 that we observe with both glial and neuronal hTDP-43 expression.
The brains of flies expressing hTDP-43 in glia display rampant cell death, seen both with
TUNEL staining (Fig 3C) and at the level of TEM (Fig 3D). To test whether the decision of
cells to commit to a programmed cell death pathway in response to hTDP-43 expression is
mediated by Loki (Chk2), we co-expressed the loki(IR) that was so effective in suppressing
hTDP-43 toxicity in survival analyses (Repo> hTDP-43 + loki(IR)) and found that this was
sufficient to abolish the dramatic accumulation of TUNEL-positive nuclei induced by glial
expression of hTDP-43 (Fig 5C and 5D). Moreover, we found that the gypsyRTE contributes
at least in part to the decision of cells to undergo programmed cell death in response to hTDP-
43 expression in glia, as knocking down gypsy (Repo> hTDP-43 + gypsy(IR)) also significantly
reduces the TUNEL labeling observed in the CNS of these animals (Fig 5C and 5D). These
effects are specific to loki(IR) and gypsy(IR) as co-expression of an unrelated UAS-(IR) con-
struct with hTDP-43 in glia (Repo> hTDP-43 + GFP(IR)) does not significantly alter the
number of TUNEL positive cells compared to brains of flies expressing hTDP-43 alone under
Repo-Gal4 (S5B Fig). Importantly, co-expression of the GFP(IR), loki(IR), and gypsy(IR) con-
structs with hTDP-43 under Repo-Gal4 also does not significantly reduce the expression of
hTDP-43 (TARDBP; S5C Fig). Differences in the level of hTDP-43 expression between these
experimental groups therefore cannot account for the phenotypic rescue observed with loki or
gypsy knock down in either the survival or cell death assays. Taken together, these data support
the conclusion that the cell death induced by hTDP-43 is mediated predominantly via Loki/
Chk2 activity in response to DNA damage, and that this DNA damage is likely induced by
RTE activity. For both the physiological toxicity and cell death induced by hTDP-43 expres-
sion in glial cells, this effect is in large part due to the activity of one particular RTE, the gypsy
ERV. These observations are in agreement with the well-documented accumulation of DNA
double strand breaks induced by unleashing RTEs [86], as well as reports that transgenic
expression of the HERV-K ENV protein in mice results in loss of volume in the motor cortex
flies expressing glial hTDP-43 (Repo > hTDP-43). (B) Co-expression of an unrelated GFP(IR) control
transgene (Repo >GFP(IR) + hTDP-43) does not effect the lifespan of flies expressing glial hTDP-43 (Repo >
hTDP-43). (C) Co-expression of gypsy(IR) (ELAV > gypsy(IR) + hTDP-43) has no effect on lifespan in flies
expressing neuronal hTDP-43 (ELAV > hTDP-43).
doi:10.1371/journal.pgen.1006635.g004
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and DNA damage [55]. While the impact of gypsy appears to be restricted to the case where
hTDP-43 is expressed in glial cells, our RNA-seq data demonstrate that expression of hTDP-
43 causes the induction of a panel of RTEs that normally would be silenced. Such results lead
us to postulate that hTDP-43 pathology might be impacting the natural mechanisms by which
RTEs in general are normally kept suppressed. We therefore designed a reporter assay to detect
the effect of hTDP-43 expression on the siRNA system, which provides the primary silencing
mechanism to keep RTEs in check in somatic tissues such as the brain.
Expression of hTDP-43 disrupts siRNA-mediated silencing
The major post-transcriptional RTE silencing system available in somatic tissue such as the
brain is the siRNA pathway [87–92]. siRNAs with sequence complementarity to RTEs have
Fig 5. DNA damage-induced cell death and gypsy ERV expression contribute hTDP-43 mediated toxicity. (A) Lifespan analysis shows that co-
expression of loki(IR) (Repo > loki(IR) + hTDP-43) fully rescues the lifespan deficit exhibited by flies expressing glial hTDP-43 (Repo > hTDP-43). (B) Co-
expression of loki(IR) (ELAV > loki(IR) + hTDP-43) likewise fully rescues the lifespan deficit exhibited by flies expressing neuronal hTDP-43 (ELAV >
hTDP-43). (C) Central projections of whole-mount TUNEL stained brains reveal a noticeable reduction in the apoptotic activity induced by glial hTDP-43
expression (Repo > hTDP-43 + GFP(IR)) when gypsy expression is knocked down (Repo > hTDP-43 + gypsy(IR)), while knocking down loki completely
alleviates the apoptosis induced by glial hTDP-43 expression (Repo > hTDP-43 + loki(IR)). (D) Quantification of (H), normalized to the positive control
(Repo > hTDP-43 + GFP(IR)). N = 12 for Repo / +; N = 9 for Repo > hTDP-43 + GFP(IR); N = 7 for Repo > hTDP-43 + gypsy(IR); and N = 7 for Repo >
hTDP-43 + loki(IR). *All of the lifespans with the exception of the NRTI feeding experiments shown in Figs 4 and 5, were performed concurrently in order
to ensure comparability across groups. Therefore, appropriate controls are shared across panels.
doi:10.1371/journal.pgen.1006635.g005
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been detected in many species, including mammals [1, 88, 93], and RTE-siRNA levels have
been demonstrated to affect RTE activity [1, 94–96]. Moreover, disruptions in the siRNA path-
way result in increased TE transcript levels [21, 91, 97] as well as novel insertions in the
genome [21, 98]. Indeed, we have previously shown that disruption of the major siRNA path-
way effector Argonaute 2 (Ago2) leads to precocious gypsy expression in Drosophila head tissue
and this is accompanied by rapid age-dependent neurophysiological decline [21]. We therefore
engineered a genetically encoded sensor system to inform us as to whether hTDP-43 expres-
sion impairs the efficiency of Dicer-2 (Dcr-2)/Ago2-mediated siRNA silencing in the Drosoph-
ila nervous system in vivo.
Our reporter system relied on three components. We co-expressed a Dcr-2 processed IR
construct directed against GFP (GFP(IR)) with a GFP transgenic reporter. By selecting an
effective GFP(IR), we were able to generate substantial silencing of the GFP reporter (Fig 6A
and 6B). To test the effects of hTDP-43 on siRNA mediated silencing, we then co-expressed
our third component: either hTDP-43 or an unrelated control transgene (tdTomato). This tri-
partite system was expressed either in all glial cells using the Repo-Gal4 driver (Fig 6A) or in
mushroom body neurons using the OK107-Gal4 driver (Fig 6B). Brains of young (2–4 day)
and middle aged (10–12 days) flies were imaged using confocal microscopy. In the case of neu-
ronal expression we were able to carry the experiment out to old age (45–47 days), but this was
not possible with glial expression of hTDP-43 as it results in dramatic reduction in lifespan
(see Fig 3B). What we observed was conspicuously reminiscent of hTDP-43’s impact on gypsy
expression. Glial expression of hTDP-43 causes a marked reduction of siRNA silencing effi-
cacy, resulting in easily detectable expression of the GFP reporter. Such expression is dramatic
and significant in brains of 2–4 day old flies and persists out to 10–12 days of age (Fig 6A).
Brains are obviously deteriorated by the 10–12 day time-point, which likely explains why GFP
levels appear to drop off somewhat. Neuronal expression of hTDP-43 in the mushroom body
has a similar but more slowly progressing effect on siRNA-mediated silencing of our GFP
reporter, with a somewhat later onset (Fig 6B). Indeed, when we perform an analogous experi-
ment using an endogenous reporter of siRNA mediated silencing in a separate structure we
observe a similar effect. The GMR-Gal4 driver, which drives high levels of expression in the fly
eye, was used to express an IR construct directed against the endogenous white+ pigment gene
in place of GFP as a reporter (Fig 6C). As with mushroom body neurons in the CNS, expres-
sion of hTDP-43 in the eye causes a progressive de-repression of the silenced reporter. It is
noteworthy that the erosion of siRNA efficacy caused by hTDP-43 expression in the eye mani-
fests as clusters of red-pigmented cells, a phenotype which is evocative of the stochastic clusters
of ENV immunoreactivity observed early in response to glial hTDP-43 expression (Fig 6C and
S2C Fig). In contrast, simply turning on expression of white+ after development results in a
uniform darkening of the eye with age (S6A and S6B Fig). Taken together, these findings dem-
onstrate that hTDP-43 expression interferes with siRNA-mediated silencing in several tissue
types, resulting in de-suppression of reporter expression. In neurons hTDP-43 expression
causes age-dependent progressive erosion of siRNA efficacy, while glial expression of hTDP-
43 results in more acute siRNA silencing impairment.
Although we have yet to identify which step of the siRNA pathway is disrupted by hTDP-43
expression, it is not simply due to loss of expression of Dcr-2 or Ago2, the two major effectors
of siRNA-mediated silencing in Drosophila [90–93]. qPCR of whole head tissue demonstrated
that hTDP-43 expression in both neurons and glial cells does not affect absolute expression
levels of Dcr-2 (S6C.1 Fig) or Ago2 (S6C.2 Fig) at either 2–4 or 8–10 days post-eclosion, there-
fore down-regulation of these molecules is not responsible for the observed de-suppression of
gypsy. In fact, in the case of genetic controls and flies expressing hTDP-43 in neurons, Dcr-2
and Ago2 levels actually increase with age beginning at 21–23 days post-eclosion and persisting
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into old age (40–42 days old), suggesting that down-regulation of Dcr-2 and Ago2 likewise can-
not explain the later elevation of gypsy expression observed in these genotypes (S6D.1–S6D.3
Fig). On the other hand, small-RNA seq from head tissue of flies expressing hTDP-43 under the
glial Repo-Gal4 driver reveals a relative reduction specifically in levels of antisense siRNAs
among the subset that target RTEs whose expression is elevated in the RNAseq data (S5 Table;
S7A and S7B Fig). This is suggestive of a defect in either biogenesis or stability of the siRNAs
that target these RTEs. We favor a model (Fig 7) in which TDP-43 protein pathology interferes
with siRNA biogenesis and/or function, resulting in deterioration of siRNA-mediated silencing
accompanied by activation of RTE expression. The resulting increase in RTE expression may
lead to accumulation of DNA damage resulting from RTE activity induced by TDP-43 pathol-
ogy, in turn activating Loki/Chk2 signaling and leading to programmed cell death (Fig 7).
Discussion
We previously reported bioinformatic predictions of a physical link between TDP-43 protein
and RTE RNAs in rodent and in human cortical tissue [54]. Here we provide in vivo functional
evidence in Drosophila that TDP-43 pathological toxicity is the result of RTE activity generally
and, in glial cells, expression of the gypsy ERV specifically. This finding is parsimonious with
reports of high levels of reverse transcriptase activity in serum and CSF of HIV-negative ALS
patients and their blood relatives [59–61], and of accumulation of transcripts and protein of
HERV-K, a human ERV of the gypsy family, in the CNS of ALS patients [50, 55]. It also is nota-
ble that accumulation of virus-like inclusions have been detected by electron microscopy in
both neurons and glia of the frontal cortex of one ALS patient with extended prolongation of
life via artificial lung ventilation [99]. Furthermore, our findings are complementary to those
documenting progressive motor dysfunction in transgenic mice expressing HERV-K ENV
protein, one of the three major open reading frames of this human RTE [55]. However, the
findings reported here provide the first demonstration that an endogenous RTE causally con-
tributes to physiological deterioration and cell death in TDP-43 protein pathology. Addition-
ally, our findings indicate that reverse transcriptase enzymatic activity contributes to the
toxicity of TDP-43 induced RTE expression, and that toxicity is largely mediated by DNA
damage-induced cell death. Finally, we demonstrate that TDP-43 pathology leads to erosion of
the post-transcriptional gene silencing mechanisms that are broadly responsible for RTE
repression, which is accompanied by elevated expression of a panel of RTEs. These findings
are in agreement with our previous observations that TDP-43 protein normally exhibits wide-
spread interactions with RTE transcripts in rodent and human cortical tissue and that these
interactions are selectively lost in cortical tissue of FTLD patients [54], as well as a report that
knocking out the C. elegans ortholog of hTDP-43 results in broad accumulation of transposon-
derived RNA transcripts and double stranded RNA [100].
Fig 6. Glial and neuronal hTDP-43 expression erodes siRNA-mediated silencing. (A) Representative central projections show that co-expression
of the hTDP-43 transgene, but not an unrelated tdTomato control transgene, interferes with the ability of a Dcr-2 processed IR (GFP(IR)) to silence a
GFP transgenic reporter in glial cells using the Repo-GAL4 driver. Quantification of GFP signal for each group is shown in the appropriate bar graph;
values are represented as relative fold change over Repo >GFP + GFP(IR) (mean + SEM). A two-way ANOVA reveals significant effects of both
genotype (p < 0.0001) and age (p < 0.0001), and a significant age x genotype interaction (p < 0.0001). N = 5 for Repo >GFP and Repo >GFP + GFP
(IR); N = 10 for all other groups. (B) An equivalent analysis demonstrates that hTDP-43 has a similar effect in the neuronal cells of the Drosophila
mushroom body using the OK107-Gal4 driver, but with a later age of onset than hTDP-43 expression in glial cells. Quantification of GFP signal for each
group is shown in the appropriate bar graph as in (A). A two-way ANOVA reveals significant effects of genotype (p = 0.0054) and age (p < 0.0001), as
well as a significant age x genotype interaction (p = 0.0021). N = 5 for OK107 >GFP and OK107 >GFP + GFP(IR); N = 10 for all other groups. (C) Co-
expression of hTDP-43, but not GFP, in the photoreceptor neurons of the fly eye under the GMR-Gal4 driver interrupts the ability of a Dcr-2 processed
IR to silence the endogenous white+ pigment gene with an age of onset similar to that observed with neuronal expression of hTDP-43 in the CNS under
OK107-Gal4, resulting in characteristic clusters of red-pigmented ommatidia. N = 5 for GMR > w(IR) + Gal80ts OFF and GMR > w(IR) + Gal80ts ON;
N = 20 for all other groups.
doi:10.1371/journal.pgen.1006635.g006
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TDP-43 has frequently been reported to co-localize with the major siRNA pathway compo-
nents, DICER and Argonaute, in both cell culture and human patient tissue. Indeed such co-
localization is commonly detected in stress granules (SGs), cytoplasmic foci for modulating
mRNA translation that materialize in response to cellular stress [34, 47, 101–104]. SGs are
observed in pathological ALS and FTLD patient tissue, and can be induced in neuronal cell
culture via overexpression of mutant and wild-type hTDP-43 as well as two other ALS linked
genes, SOD1 and FUS, suggesting that they may represent a common downstream mechanism
of pathological progression [47]. And SG formation in response to cellular stressors, or overex-
pression of ALS-linked genes including hTDP-43, inhibits DICER processing of pre-miRNAs
to mature miRNAs [47]. This signature is detectable in both sporadic and familial ALS spinal
column motor neurons as a dramatic global reduction in mature miRNAs in comparison to
control tissue [47]. These findings are in accordance with previous work by Kawahara and
Mieda-Sato (2012), which showed that loss of hTDP-43 function itself inhibits cytoplasmic
miRNA processing by DICER for at least a subset of miRNAs [45]. In mammals, the same
DICER and Argonaute proteins process both miRNAs and siRNAs [105]. Therefore, the
effects of SG formation and hTDP-43 manipulation on DICER function may affect siRNAs
just as dramatically as miRNAs, however the effects of TDP-43 expression on siRNA function
Fig 7. A cellular model for RTE mediated DNA damage and apoptotic cell death in TDP-43 pathology. In a healthy cell TDP-43 protein is
predominantly found in the nucleus with the capacity to shuttle between the nucleus and the cytoplasm. This pleiotropic protein plays many important roles
in normal RNA metabolism in both cellular compartments (A). Cells that experience TDP-43 pathology exhibit accumulation of TDP-43 protein in dense
cytoplasmic inclusions and clearance from the nucleus (B). This is accompanied by rapid deterioration of siRNA-mediated silencing, as well as activation of
RTE expression (C). The apoptotic cell death (F) induced by TDP-43 pathology is largely mediated by Loki/Chk-2 signaling (E). In the case of hTDP-43
pathology in fly glial cells in the CNS, expression of the gypsy RTE contributes to hTDP-43-induced cell death. Based on this observation, as well as the
known cell biological role of Loki/Chk-2, we infer that the apoptosis induced by TDP-43 pathology is largely the result of Chk-2 activation in response to TDP-
43-induced DNA damage (D), and that this DNA damage is at least partially incurred by TDP-43’s effects on RTEs (C).
doi:10.1371/journal.pgen.1006635.g007
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in mammals have as yet to be investigated. In contrast with the mammalian system, siRNAs
and miRNAs in Drosophila are processed largely via distinct pathways–Dcr-1/Ago1 and Dcr-
2/Ago2, respectively [105]. This disparity provided an opportunity for us to engineer an in
vivo sensor to investigate the effects of TDP-43 on the siRNA system separate from its effects
on miRNA biogenesis. While production of some miRNAs is disrupted in both animal models
of ALS and human patient tissue, our data clearly demonstrate that in Drosophila, pathological
TDP-43 expression disrupts the siRNA function of the DICER/Ago pathway. This finding
dovetails with a report that the C. elegans TDP-43 ortholog impacts accumulation of double
stranded RNA, which is the substrate of the DICER enzyme [100]. Our findings support the
conclusion that the disruption of siRNA silencing contributes to cellular toxicity, dramatic
physiological deterioration, and premature death via loss of control of RTEs.
Unregulated RTE expression is known to be highly toxic in other biological contexts for a
number of reasons, including accumulation of toxic RNAs, creation of harmful mutations,
and accumulation of DNA damage. In the case of gypsywe demonstrate that this RTE has a
causal impact on cell death and physiological decline in the animal’s health. We also identify
DNA damage-induced cell death, mediated by Chk2 activity, as a major contributing factor in
the toxicity of TDP-43 both at the cellular and organismal level. Importantly, gypsy is not the
only RTE whose expression we found to be increased in response to hTDP-43 expression. We
in fact observe a panel of RTEs that exhibit elevated expression, with some variation in this
profile when hTDP-43 is expressed solely in neurons or glia. This is consistent with the obser-
vation that knocking down gypsy expression only partially suppresses the toxicity of TDP-43,
whereas blocking loki (chk2) expression leads to a near complete suppression of the effects of
hTDP-43 expression on cell death and lifespan reduction. The involvement of DNA damage-
induced cell death suggest that gypsy and likely other RTEs may be successfully or abortively
inserting into genomic DNA, although we are mindful of the fact that increased levels of RTE
proteins and RNAs may themselves be cytotoxic, as is observed with the Alu RTE in macular
degeneration [52].
In the case of HERV-K, it has recently been shown [55] that TDP-43 binds directly to the
LTR at the DNA level, thereby activating transcription of HERV-K. Our results establish, how-
ever, that TDP-43 pathology also compromises the siRNA-mediated gene silencing system,
which is the major post-transcriptional genomic defense against RTEs in somatic tissues. The
mechanisms by which TDP-43 protein pathology disrupts siRNA silencing remain to be inves-
tigated, but we favor the idea that it involves direct interactions between TDP-43 and the
siRNA protein machinery [45, 47], and our previous findings also suggest direct interaction
with RTE RNAs [54]. The disruptive impact of TDP-43 on the siRNA system points to a gen-
eral loss of RTE silencing—as opposed to activation of a specific element such as the gypsy
ERV (or HERV-K)—as the major contributing factor in hTDP-43-related neurophysiological
deterioration. This conclusion is supported by our RNA-seq data which shows a broad and
general increase in RTE expression in head tissue of Drosophila expressing either neuronal or
glial hTDP-43, as well as a pronounced reduction specifically in antisense siRNAs which target
the RTEs we observe to exhibit increased expression in response to hTDP-43 expression. In
accordance with this notion, we have previously shown in Drosophila that mutation of Ago2, a
major effector protein of the siRNA system, results in activation of several different RTEs in
brain tissue and causes rapid age-related cognitive decline and shortened lifespan [21].
Like Drosophila, the human genome contains more than one type of functional RTE. In
addition to HERV-K, the human genome contains on the order of 100 fully active copies of
L1 RTEs, and a far higher number of non-autonomous elements that replicate in trans by
capitalizing on the protein machinery encoded by L1s [106]. Moreover, abnormally high
levels of expression of several different RTE families has been reported across a suite of
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neurodegenerative diseases [50–57], and there is accumulating evidence suggesting RTEs gen-
erally become active with advanced age in a variety of organisms and tissues [13–18], including
the brain [21]. Previous studies make the case that this effect may result from age-related loss
of transcription-level heterochromatic silencing [16, 18]. Our finding that TDP-43 erodes
post-transcriptional, siRNA-mediated RTE silencing therefore raises an intriguing hypothesis
regarding the synergy between age and TDP-43 pathology on RTE activation, particularly
when the reinforcing action of siRNAs on heterochromatin is taken into consideration [1, 18].
This potential synergy, in conjunction with the replicative capacity encoded by RTEs, leads us
to posit the “retrotransposon storm” hypothesis of neurodegeneration. We envision that loss
of control of RTE expression and replication leads to a feed-forward mechanism in which mas-
sive levels of activity drive toxicity and degeneration in the nervous system. Our findings are
not in conflict with a wealth of data that have implicated effects of TDP-43 pathology on splic-
ing, RNA stability, translation, and miRNA biogenesis [28, 29, 38, 39, 45–47]., and it will be
important to conceptually integrate our findings with these other aspects of TDP-43 pathology.
But the direct impact we observe on cell death highlights the importance of investigating the
contribution of siRNA dysfunction and RTE toxicity in TDP-43-mediated pathogenesis, and
may indicate a promising common avenue for novel therapeutic targets in both familial and
sporadic cases of ALS.
Materials and methods
Fly stocks
All transgenic fly stocks used, with the exception of w(IR) and GMR-Gal4, were backcrossed
into our in-house wild type strain, the Canton-S derivative w1118 (isoCJ1) [107], for at least five
generations to homogenize genetic background. The GFP, OK107-, ELAV-, and Repo-Gal4
lines [108], as well as the hTDP-43 [68] and gypsy(IR) [57] lines, are as reported previously.
The GMR-Gal4, Gal80ts, w(IR), GFP(IR), and tdTomato lines were acquired from the Bloom-
ington Drosophila Stock Center (stock numbers: 43675, 7019, 25785, 9331, and 32221; respec-
tively), and the loki(IR) line was acquired from the Vienna Drosophila Resource Center [109]
(stock number: v44980). Flies were cultured on standard fly food at room temperature unless
otherwise noted.
Bleach treatment of embryos
All fly stocks used for lifespan analysis and longitudinal qPCR experiments were double
dechorionated by bleach treatment in order to remove exogenous viral infection [21]. Briefly,
4-hour embryos were collected and treated with 100% bleach for 30 min to remove the cho-
rion. Treated embryos were washed and subsequently transferred to a virus-free room
equipped with ultraviolet lights to maintain sterility. This was repeated for at least two succes-
sive generations and expanded fly stocks were tested via qPCR of whole flies to ensure Dro-
sophila C Virus (DCV) levels were below a threshold of 32 cycles.
RNA-seq and small RNAseq library preparation
Fly heads were collected for each genotype and total RNA was purified with Trizol (Invitro-
gen). RNA-Seq libraries were constructed using the NuGEN Ovation Drosophila RNA-Seq kit
including DNase treatment with HL-dsDNase (ArcticZymes Cat. # 70800–201) and cDNA
fragmentation using the Covaris E220 system according to manufacturer specifications. After
amplification, library quality was measured using the Agilent Bioanalyzer system and quantity
was determined using Life Technologies Qubit dsDNA HS Assay kit (for use with the Qubit
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2.0 Fluorometer). Prior to sequencing, pooled libraries were quantified using the Illumina
Library Quantification kit (with Universal qPCR mix) from Kapa Biosystems and a 1.2 pM
loading concentration was used for PE101 on the Illumina NextSeq500 platform. Small RNAs
were cloned using TruSeq (Illumina) approach with modifications described in Rozhkov 2015
[110]. Briefly, all small RNA libraries were constructed from 15–20 ug of TRIzol isolated total
RNA. 18–29 nucleotide long small RNAs were size selected on 15% PAGE-UREA gel. After 3’-
and 5’-adapter ligation, subsequent gel purification steps and reverse transcription cDNAs
were PCR amplified with barcoded primers. PCR products were size selected on 6% PAGE gel,
and quantified on Bioanalyzer. Loading concentrations were determined using the NEBNext
Library Quant kit for Illumina (NEB). The libraries were sequenced on NEXTSeq platform.
Sequencing, mapping and annotation
RNA-seq libraries were run on an Illumina NextSeq (paired end 101). Reads were mapped to
the Drosophila dm3 genome with STAR [111] allowing up to 4 mismatches and a maximum of
100 multiple alignments. To estimate the pileup along gypsy element, reads were mapped to
the gypsy consensus sequence (GenBank accession: M12927) using Bowtie [112] with up to 2
mismatches. Reads were annotated based on genomic locations against ribosomal RNAs,
transposable elements (FlyBase), and RefSeq genes (UCSC genome database RefSeq track).
The GEO accession number for all RNAseq and smallRNAseq data is GSE85398 (https://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85398).
Transcriptome analysis
Reads mapped to ribosomal RNAs were removed from each library. For the remaining reads,
expression abundance estimation and differential expression analysis were performed using
the TEtranscripts package [76]. Reads for each library were normalized based on library size,
e.g., reads per million mapped (RPM). Statistically significant differences were taken as those
genes/transposons (TEs) with a Benjamini-Hochberg corrected P-value < 0.05, as calculated
by DESeq [113]. Biological replicates were averaged for the purpose of estimating pileup along
consensus TEs.
Enrichment analysis for KEGG ALS pathway
The ortholog pairs of fly and human were predicted with the Drosophila Integrated Ortholog
Prediction Tool (DIOPT), which integrates the ortholog predictions from 11 existing tools
[114]. The pairs with the “high” rank, defining as the best match with both forward and reverse
searches and the DIOPT score is at least 2, were selected. Then we performed Fisher’s exact
test to check if the differential expression fly genes are enriched in the KEGG ALS human
genes with identifiable fly orthologs.
Lifespans
Male flies were used for all lifespan assays since the majority of glial-expressing hTDP-43 flies
that escape their pupal cases are male. Flies were housed 15 to a vial with a total of 75 flies per
genotype and flipped into fresh food vials every other day. All vials were kept on their side in
racks for the duration of the experiment. Lifespan experiments were performed blind.
NRTI food preparation and lifespans
Tenofovir disoproxil fumarate (TDF; Selleck Chemicals, CAS 147127-20-6), Zidovudine
(AZT; Sigma-Aldrich, CAS 30516-87-1), and Stavudine (d4T; Sigma-Aldrich, CAS 3056-17-5)
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were prepped as solutions using dimethyl sulfide (DMSO) as solvent. Standard fly food was
melted and cooled to a liquid, and NRTI solutions were added just before solidification to give
final concentrations of 0 (vehicle alone control), 1, 5, 10, and 15 μM of each NRTI in a total
volume of 0.2% DMSO, then stored at 4˚C for a maximum of 2 weeks until use. Lifespan was
monitored in all male flies with 20 flies per vial for a total of 100 flies monitored per genotype
per treatment. Lifespans were performed as above.
CAFE assays
To quantify and determine the consistency of feeding across treatments, Capillary Feeder
(CAFE) Assays [115] were performed. Each replicate consisted of five male wild-type flies con-
tained in a 1.5 mL microfuge tube chamber with 1% agarose in bottom to maintain humidity
and two 5 μL disposable calibrated pipets (VWR, 53432–706) providing the media solution
(5% sucrose / 5% autolyzed yeast extract, Sigma-Aldrich), inserted though the tube cap. Flies
were acclimated with untreated solution ad libitum for 24 hours. Measurements were initiated
one hour following the switch to experimental solutions and monitored for a total duration of
24 hours. Experimentally treated solutions were prepared to match the concentrations of each
NRTI treatment used in solid food for lifespan analysis, as well as an additional solution of
high concentration for each NRTI (100 μM) and a solution of vehicle alone control (0.2%
DMSO). Displacement due to evaporation was controlled for by subtracting measurements
from fly-less CAFE chambers with the vehicle solution set up in parallel to the experimental
assays. CAFE assays with untreated solution were also set up in parallel and controlled for
evaporation.
Locomotion behavior assay
Locomotion behavior was assayed using the classic Benzer counter current apparatus as in
Benzer, S., 1967 [116], with the following modifications: freshly eclosed flies were transferred
into glass bottles with food and a paper substrate and plugged with foam stoppers. Flies were
transferred to fresh bottles every 48 hours until they reached the appropriate age for locomo-
tion assays. The Benzer assay was conducted in a horizontal position with a fluorescent light
source to measure phototaxis. Locomotion assays were performed blind.
qPCR and TaqMan probes
Tissue preparation, cDNA synthesis and qPCR were performed as previously described [21] using
the Applied Biosystems StepOnePlus Real-Time PCR System. Heads of 75–100 flies were used for
each biological replicate unless otherwise noted. All TaqMan Gene Expression Assays were acquired
from Applied Biosystems and used the FAM Reporter and MGB Quencher. The inventoried assays
used were: Act5C (assay ID Dm02361909_s1), Dcr-2 (assay ID Dm01821537_g1), Ago2 (assay ID
Dm01805433_g1), TARDBP (assay ID Hs00606522_m1), TBPH (assay ID Dm01820179_g1), and
loki (assay ID Dm01811114_g1). All custom TaqMan probes were designed following the vendor’s
custom assay design service manual and have the following assay IDs and probe sequences: gypsy
ORF2 (assay ID AI5106V; probe: 5’–AAGCATTTGTGTTTGATTTC-3’), gypsyORF3 (assay ID
AID1UHW; probe: 5’-CTCTAGGATAGGCAATTAA-3’), and DCV (assay ID AIPAC3F; probe:
50-TTGTCGACGCAATTCTT-30). For genomic QPCR, DNA was isolated from 2–4 day old flies
(equal numbers per sample, 50% male/female). After RNAase treatment, equal input levels of DNA
were used for each PCR reaction, and each reaction was performed in triplicate. The CT values for
GypsyORF2 were normalized to those for Actin within each sample. The values shown S2A.5 Fig
were then further normalized to the levels in the wild type strain in order to display relative fold
change over our wild type strain.
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Whole mount immunohistochemistry and GFP imaging
Dissection, fixation, immunolabelling, and confocal imaging acquisition were executed as pre-
viously described [117]. The ENV primary antibody was used as described in Li, et al. 2013
[21, 78]. For TDP-43 immunohistochemistry, the primary full length human TDP-43 antibody
(Protein Tech, 10782-2-AP) was used at a 1:100 dilution, and the primary pSer409 phosphory-
lated human TDP-43 antibody (Sigma Aldrich, SAB4200223) was used at a 1:500 dilution
separately in conjunction with a 1:200 dilution of an Alexa Fluor 488-conjugated secondary
antibody (Thermo Fisher Scientific, A-11070). Repo co-labeling was performed using a 1:200
dilution of primary antibody (Developmental Studies Hybridoma Bank, 8D12) and a 1:200
dilution of a Cy3-conjugated secondary antibody (Molecular Probes, A10521). DAPI co-stain-
ing was performed after a brief wash in 1x PBS immediately subsequent to secondary antibody
staining using DAPI Dilactate (Thermo Fisher Scientific, D3571) as per manufacturer specifi-
cations. All brains co-stained with DAPI were imaged on a Zeiss LSM 780 confocal microscope
using a UV laser and the Zeiss ZEN microscope software package.
GFP quantification
The gain on the confocal microscope was set using the positive control (Repo> GFP or OK107
> GFP) and kept consistent across all subsequent brains imaged. The GFP signal of the
median 10 optical sections of the appropriate structures (either the full brain for Repo or both
lobes of the calyx for OK107, respectively) was calculated using ImageJ software, as previously
described [118]. These ten values were then averaged, and this number used as a representa-
tion for each individual brain. 5–10 brains were analyzed per group.
TUNEL-positive nuclei detection and quantification
For TUNEL staining, the In Situ Cell Death Detection Kit, TMR red (Roche, 12156792910)
was used. The same dissection, fixation, and penetration and blocking protocol used for anti-
body staining was followed [117], at which point the brains were transferred to the reaction
mix from the kit for 2 hours at 4˚C followed by 1 hour at 37˚C. Brains were then washed,
mounted, and imaged as previously described [117]. For imaging, the gain on the confocal
microscope was set using the positive control (Repo> hTDP-43) and kept consistent across all
subsequent brains imaged. A projection image was generated using the middle 50 optical slices
from the z-stack image of the whole brain. This projection image was then thresholded using
the maximum entropy technique (See: [119]) via the Fiji plug-in for ImageJ software, and the
subsequent binary image was subjected to puncta quantification using ImageJ software. Puncta
quantification was thresholded for puncta greater than 3 pixels to reduce the likelihood of
counting background signal. The total number of puncta counted was then used as a represen-
tation for the number of TUNEL-positive nuclei for each brain in subsequent statistical analy-
sis. 7–12 brains were analyzed per group. Quantification of gypsyENV immunoreactive
puncta was performed in the same manner.
Drosophila eye imaging
Flies of the appropriate age and genotype were placed at -70˚C for 25 minutes and then kept
on ice until immediately prior to imaging. Imaging was performed using a Nikon SMZ1500
stereoscopic microscope, Nikon DS-Vi1 camera and Nikon Digital Sight camera system,
and the Nikon NIS-Elements BR3.2 64-bit imaging software package. The experiment was
designed such that each group is balanced for the number of mini-white transgenes and het-
erozygous for genomic white+.
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Transmission electron microscopy
Drosophila heads were removed, the cuticle removed and the brains fixed overnight in 2%
paraformaldehyde and 2% glutaraldehyde in 0.1 mol/L PBS. Samples were rinsed in distilled
water and post-fixed for one hour in 1% osmium tetroxide in 1.5% potassium ferrocyanide in
distilled water. Next, the samples were dehydrated in a graded series of ethanol and the final
100% ethanol was replaced with a solution of absolute dry acetone (Electron Microscopy Sci-
ences, Hatfield PA). The samples were then infiltrated with agitation for one hour in an equal
mixture of acetone and Epon-Araldite resin, followed by infiltration with agitation overnight
in 100% resin. Samples were transferred to embedding capsules with the posterior head facing
towards the bottom of the capsule and the resin was polymerized overnight in a vented 60˚C
oven. Thin sections were made from the mushroom body region and collected on Butvar
coated 2mm x 1mm slot grids (EMS) and the sections were counterstained with lead citrate.
Thin sections were imaged with a Hitachi H700 transmission electron microscope and
recorded on Kodak 4480 negatives that were scanned with an Epson V750 Pro Scanner at 2400
DPI. 3 individual brains processed for Repo / +, 4 individual brains processed for Repo>
hTDP-43; many images collected of each brain.
Statistics
For qPCR data, the p-values of all data sets with only two groups were calculated using an
unpaired t-test. Where an effect of age for more than two time points within one genotype was
determined, a one-way ANOVA was performed, and where multiple ages and genotypes are
represented a two-way ANOVA was performed; the results are reported in the figure legends.
All pairwise comparisons for qPCR reported in the figures were corrected using the Bonferroni
method for multiple comparisons. For both the locomotion data and the GFP quantification,
p-values were reported using the Sheffe´ method; ANOVA results are reported in the figure leg-
ends. The CAFE assay is similarly reported, with pairwise comparisons between treatments
being made using one-way ANOVA with Tukey’s Multiple Comparisons test. Survival analyses
for the lifespan curves were performed using the Kaplan-Meier method, and the Gehan-Bre-
slow-Wilcoxon test were used to compare survival curves. All pairwise comparisons for life-
span curves were corrected using the Bonferroni method. Sample sizes were selected based on
standard practices in the literature. No randomization was employed in this study.
Supporting information
S1 Fig. Differentially expressed genes in Repo-TDP-43 heads enriches for fly orthologs of
ALS-KEGG gene set. Among the KEGG gene set annotated as functionally related to ALS
pathways. Although this is by no means a complete list of genes that have been implicated in
ALS in the literature, it represents a set of gene pathways with known involvement in ALS. 20
of the ALS KEGG gene set contain clear Drosophila orthologs and a significant fraction of
these (11/20) are identified as differentially expressed in our RNAseq from Repo>TDP-43
heads.
(PDF)
S2 Fig. gypsy expression turns on stochastically in young brains and reaches peak expres-
sion in the population at mid-adulthood. (A) Transcript levels of gypsy ORF3 (Env) as
detected by qPCR on whole head tissue of flies expressing (A.1) neuronal hTDP-43 (ELAV >
hTDP-43), or genetic controls: (A.2) ELAV / + and (A.3) hTDP-43 / +. gypsy ORF3 transcript
levels display an increase by 21–23 days post-eclosion that drops back down by 40–42 days
post-eclosion, regardless of genotype. In all cases transcript levels have been normalized to
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Actin, and the aged cohort (8–10 days; 21–23 days; 40–42 days) are represented as a fold change
over an appropriate young (2–4 day) cohort that has been processed in parallel. Unpaired t-tests
have been used to calculate p-values for each aged cohort with its matched young cohort, while
p-values comparing aged cohorts within genotypes have been calculated using the Bonferroni
method for multiple comparisons. For all three genotypes a one-way ANOVA shows a significant
effect of age on gypsyORF3 transcript levels between the aged cohorts (ELAV > hTDP-43, p<
0.0001; ELAV / +, p< 0.0001; hTDP-43 / +, p = 0.0346). N = 5 for all groups. (A.4). qPCR of
whole head tissue reveals that the presence of the hTDP-43 transgene alone with no Gal4 driver
results in elevation of gypsyORF2 transcript levels. N = 6 for both groups. Quantitative genomic
PCR (A.5) reveals that the wild type, Elav-Gal4 and Repo-Gal4 lines have comparable levels of
gypsyDNA copy number, and (A.6) mRNA expression levels. The UAS-hTDP-43 parental line
exhibits marginally higher levels of gypsy genomic DNA (A.5), although this cannot explain the dif-
ference between expression in ELAV > hTDP-43 vs Repo> hTDP-43. (B) Quantification of immu-
noreactive puncta averaged across the central 10 optical slices of brains of flies expressing hTDP-43
in glial cells (Repo> hTDP-43) and genetic controls (Repo / + and hTDP-43 / +) aged to
10 days and whole-mount immunostained using the gypsy ENV monoclonal antibody in a
separate experiment from Fig 1C. A one-way ANOVA reveals that there is no difference in
ENV immunoreactivity between the two genetic control groups (Repo / + and hTDP-43 / +;
p = 1.0000), but that 10 day old flies that express hTDP-43 in glial cells (Repo> hTDP-43) dis-
play significantly more ENV immunoreactive puncta than flies carrying the UAS-hTDP-43
transgene (hTDP-43 / +; p< 0.0001) or Repo-Gal4 alone (Repo / +; p < 0.0001). Displayed
as means + SEM; N = 8 for all groups. (C) Projections through whole-mount brains immuno-
labeled with a gypsy ENV monoclonal antibody demonstrate that gypsy expression turns on
post-developmentally, with very little gypsy expression immediately following eclosion (0
Days) in genetic controls (hTDP-43 / + and Repo / +) and in flies expressing hTDP-43 in glia
(Repo> hTDP-43). Expression turns on stochastically at 3 days post-eclosion only in the
CNS of flies expressing glial hTDP-43. Replicates of 3-day old Repo> hTDP-43 brains illus-
trate the variability of gypsy expression at this early time point. N = 2 for all 0 Day groups;
hTDP-43 / +, 3 Day, N = 3; Repo / +, 3 Day, N = 4; Repo> hTDP-43, 3 Day, N = 7.
(PDF)
S3 Fig. Characterizing hTDP-43 expression. (A) TUNEL staining reveals very little apoptotic
activity when hTDP-43 is expressed in the mushroom body under OK107-Gal4, even when the
animals are aged to 30 days post-eclosion. Mushroom bodies marked by co-expression of GFP,
shown in green; TUNEL staining shown in red. OK107> GFP, 5 Day, N = 3; OK107> GFP
+ hTDP-43, 5 Day, N = 5; OK107> GFP, 30 Day, N = 5; OK107> GFP + hTDP-43, 30 Day,
N = 4. (B) Full length human TDP-43 (green) can be detected by immunolabelling in the brains
of flies expressing glial hTDP-43 under the Repo-Gal4 driver at 21–23 days post-eclosion, and co-
localizes with Repo (red) immunoreactivity (left). Repo / + (N = 4); Repo> hTDP-43 (N = 4).
Immunoreactivity for a disease-specific phosphorylated isoform of the protein (pSer409) can also
be readily detected and co-localizes with Repo (right). Repo / + (N = 7); Repo> hTDP-43 (N = 4).
A 63x blow-up is shown in the pop-out. (C) Both the full-length (left) and disease specific (right)
isoforms of hTDP-43 (green) are mainly observed in the cytoplasm and vacate the nucleus (visu-
alized by DAPI co-staining, shown in blue). Arrowheads indicate the hTDP-43-filled cytoplasm
of a cortical glial cell wrapped around several neuronal nuclei in the neuropil of flies expressing
glial hTDP-43. For full length hTDP-43 antibody, Repo / + (N = 6), Repo> hTDP-43 (N = 13);
for pSer409 phosphorylated hTDP-43 antibody, Repo / + (N = 4), Repo> hTDP-43 (N = 9). (D)
qPCR of whole head tissue demonstrates that transcript levels of hTDP-43 diminishes under
Repo-Gal4 from 2–4 days to 8–10 days. Transcript levels normalized to Actin and displayed as
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fold change relative to 2–4 day old flies (means + SEM). N = 6 for all groups. (E) A similar
effect of age on hTDP-43 expression is observed in neurons under ELAV-Gal4, and contin-
ues to drop off by 40–42 days post-eclosion. A one-way ANOVA shows a significant effect
of age (p < 0.0001). N = 6 for all groups.(F) qPCR of whole head tissue demonstrates that
expression of hTDP-43 does not effect levels of the Fly ortholog, TBPH, regardless of cell
type of expression. Transcript levels normalized to Actin. N = 4 for the hTDP-43 / + group,
N = 5 for all other groups.
(PDF)
S4 Fig. NRTI administration does not affect fly feeding behavior and expression of IR con-
structs individually does not affect lifespan or hTDP-43 expression. However, NRTI
administration extends lifespan in flies expressing hTDP-43 in glia. (A) qPCR on head tis-
sue demonstrates that expressing an IR directed against gypsy ORF2 (gypsy(IR)) in neurons
(ELAV > gypsy(IR)) or glia (Repo> gypsy(IR)) effectively inhibits age-dependent elevation of
gypsy transcript levels, and results in an ~2.5-fold reduction at 28 days post-eclosion. gypsy
transcript levels from head tissue of young (2–4 day) and aged (28 day) flies was normalized to
Actin and displayed as fold change in 28 day old flies of each genotype relative to each respec-
tive young cohort (displayed as means + SEM). A one-way ANOVA shows a significant effect
of genotype (p = 0.0182). N = 2–3 biological replicates generated from heads of 5 mL of flies
for each group. (B) Expression of gypsy(IR), loki(IR), and GFP(IR) individually in glial cells
under the Repo-Gal4 driver does not significantly alter lifespan. (C) Expression of gypsy(IR)
and loki(IR) individually in neurons under the ELAV-Gal4 driver does not significantly alter
lifespan. (D) The presence of each of the IR constructs alone without any Gal4 driver (gypsy
(IR) / +; loki(IR) / +; GFP(IR) / +) only moderately effects lifespan. (E) The capillary feeder
(CAFE) assay demonstrates that neither the final concentration of vehicle (0.2% DMSO)
alone, any of the final concentrations of D4T used in solid fly food in the lifespan analysis (Fig
4D; 1 μM, 5 μM, 10 μM, or 15 μM D4T in 0.2% DMSO), or an additional high concentration
of D4T (100 μM in 0.2% DMSO) significantly altered displacement by consumption by wild
type flies of a liquid media solution (5% sucrose / 5% autpolyzed yeast) (one-way ANOVA;
p = 0.2137) over the course of 24 hours. Fly-less assay tubes containing vehicle solution alone
were used to control for evaporation. Displayed as means + SEM; N = 6–8 for all D4T groups.
(F) CAFE assay performed as in S5E Fig demonstrates that AZT does not significantly alter
feeding behavior of wild type flies (p = 0.0595) at any of the concentrations used in solid fly
food in lifespan analyses (Fig 4E; 1 μM, 5 μM, 10 μM, or 15 μM AZT in 0.2% DMSO) or at an
additional high concentration of AZT (100 μM in 0.2% DMSO). Displayed as means + SEM;
N = 9–12 for all AZT groups. (G) Lifespan analysis shows that the NRTI Stavudine (D4T) par-
tially suppresses the lifespan deficit induced by glial expression of hTDP-43 (Repo> hTDP-43)
when supplied in solid fly food at final concentrations of either 5 μM, p = 0.0450; or 10 μM,
p = 0.0186; in comparison to vehicle alone control (0 μM). (H) Lifespan analyses performed as
in (D) for the NRTI Zidovudine (AZT). AZT partially suppresses the lifespan deficit exhibited
by flies expressing hTDP-43 in glia (Repo> hTDP-43) when supplied at 5 μM (p = 0.0245) in
comparison to a vehicle alone control (0 μM).
(PDF)
S5 Fig. Co-expression of IR constructs does not alter hTDP-43 expression level. (A) An
equivalent analysis as described for (S5A) demonstrates that neuronal (ELAV > loki(IR)) and
glial (Repo> loki(IR)) expression of an IR directed against loki (loki(IR)) effectively blocks the
age-dependent elevation of loki transcript levels, resulting in an ~2-fold reduction at 28 days
post-eclosion. A one-way ANOVA shows a significant effect of genotype (p = 0.0039). N = 3–4
biological replicates. (B) Co-expression of GFP(IR) with hTDP-43 under Repo-Gal4 (Repo
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> hTDP-43 + GFP(IR)) does not significantly alter the number of TUNEL-positive nuclei
detected compared to hTDP-43 expression alone under Repo-Gal4 (Repo> hTDP-43). N = 8
for Repo> hTDP-43 and N = 9 for Repo> hTDP-43 + GFP(IR); data normalized to Repo>
hTDP-43. (C) qPCR for hTDP-43 expression (TARDBP) on whole head tissue demonstrates
that co-expression of each of the IR constructs with hTDP-43 under Repo-Gal4 (Repo> hTDP-
43 + GFP(IR), Repo> hTDP-43 + gypsy(IR), and Repo> hTDP-43 + loki(IR), respectively)
does not significantly reduce hTDP-43 expression levels compared to hTDP-43 expression
alone under Repo-Gal4 (Repo> hTDP-43) Fold change is displayed as the mean fold change rel-
ative to Repo> hTDP-43, while p-value represents the p-value of a two-tailed Student’s t-test in
comparison to Repo> hTDP-43. N = 4 for all groups.
(PDF)
S6 Fig. Turning on white+ expression post-developmentally rescues red eye pigmentation
in Drosophila. Loss of suppression of gypsy cannot be explained by hTDP-43- or age-
dependent effects on siRNA effector molecules. (A) Schematic representation of the experi-
mental design. (B) Representative images demonstrating that turning off w(IR) expression
post-developmentally rescues red pigmentation of the Fly eye. N = 5 for all groups. (C) qPCR
of whole head tissue demonstrates that reduced expression of (C.1) Dcr-2 and (C.2) Ago2 can-
not account for loss of suppression of gypsy in flies expressing glial hTDP-43 (Repo> hTDP-
43) at either 2–4 or 8–10 days post-eclosion. Transcript levels normalized to Actin and dis-
played as fold change relative to flies carrying the hTDP-43 transgene with no Gal4 driver
(hTDP-43 / +) at 2–4 Days (means + SEM). For Dcr-2, a two-way ANOVA reveals an effect of
age (p = 0.0006) but no effect of genotype (p = 0.1081); for Ago2, a two-way ANOVA also
reveals an effect of age (p = 0.0258) but no effect of genotype (p = 0.1591). N = 8 for all groups.
(D) qPCR of whole head tissue demonstrates that age-dependent changes in expression of
Dcr-2 (top) and Ago2 (bottom) cannot account for age-dependent loss of suppression of gypsy
in flies expressing neuronal hTDP-43 (ELAV > hTDP-43; D.1) or genetic controls: (D.2)
ELAV / + and (D.3) hTDP-43 / +. All data analyzed as in (S1A.1-S1A.3); one-way ANOVA
shows an effect of age across almost all groups (ELAV > hTDP-43, Dcr-2, p < 0.0001, Ago2,
p = 0.0269; ELAV / +, Dcr-2, p< 0.0001, Ago2, p = 0.0051; hTDP-43 / +, Dcr-2, p< 0.0001,
Ago2, p = 0.3967). N = 8 for all groups.
(PDF)
S7 Fig. Expression of hTDP-43 results in a loss of siRNAs anti-sense to RTEs whose expres-
sion is increased. Sequencing of small-RNAs from heads detects siRNAs that are predicted to
target broad range of RTEs. Among RTEs whose expression is elevated in Repo>TDP-43 (vs
control), there is a selective decrease in anti-sense relative to sense stranded siRNAs. (A) scat-
ter plots of log2Fold change in RNAseq vs log2Fold change in small-RNA seq. 3S18, mdg3
and gypsy exhibit elevated levels of expression in the RNAseq data (see Fig 1), and also exhibit
decreased anti-sense/sense siRNA ratio. This is in contrast to Burdock, whose RNA levels are
unchanged and whose siRNA anti-sense/sense ratio is unchanged. (B) Overall, there is a signif-
icant decrease in anti-sense/sense ratio for the subset of siRNAs that map to TEs whose levels
are altered by Repo>hTDP-43.
(PDF)
S1 Table. Mapping statistics for RNA-seq.
(XLSX)
S2 Table. A: Abundance of gene-derived transcripts in head tissue of flies expressing pan-neu-
ronal hTDP-43 compared to controls. B: Abundance of transposon-derived transcripts in head
tissue of flies expressing pan-neuronal hTDP-43 compared to controls. C:Fly orthologs of ALS
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KEGG gene set.
(XLSX)
S3 Table. A: Abundance of gene-derived transcripts in head tissue of flies expressing pan-glial
hTDP-43 compared to controls. B: Abundance of transposon-derived transcripts in head tis-
sue of flies expressing pan-glial hTDP-43 compared to controls.
(XLSX)
S4 Table. Expression levels (RPM) of fly TBPH and hTDP-43.
(XLSX)
S5 Table. Summary statistics for small RNA seq mapping.
(XLSX)
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